Benaroya Research Institute At Virginia Mason
501C3 Nonprofit Organization Information
Benaroya Research Institute At Virginia Mason is a 501(c)(3) charitable nonprofit in Seattle, Washington (EIN 91-0653422). It has been tax-exempt since August 1958, and contributions to it are tax-deductible. Its Form 990 for tax year 2024 reports total revenue of $81,277,408 and net assets of $57,599,036. TaxExemptWorld has Form 990s on file for 15 tax years (2009–2024). The IRS classifies its activity as Biomedicine, Bioengineering Research (NTEE H920). It is one of 13,270 nonprofits in Seattle, WA.
Form 990 · Tax period ending Jun 2025 · Filed May 13, 2026 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): TO ADVANCE THE SCIENCE THAT WILL PREDICT, PREVENT, REVERSE, AND CURE DISEASES OF THE IMMUNE SYSTEM SUCH AS AUTOIMMUNE DISEASE, ALLERGY, AND ASTHMA.
TRANSLATIONAL IMMUNOLOGY AND ADVANCEMENTS OF THE IMMUNE TOLERANCE NETWORK (ITN) ARE HIGHLIGHTED BELOW:FUNDING FOR THE IMMUNE TOLERANCE NETWORK (ITN) WAS INITIALLY AWARDED TO JERRY NEPOM, MD, PHD, AT BRI IN 2014 BY THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) OF THE NATIONAL INSTITUTES OF HEALTH (NIH). IT WAS LATER RENEWED FOR A SECOND GRANT CYCLE IN 2021, PROVIDING APPROXIMATELY $27 MILLION ANNUALLY TO SUPPORT ITN. THIS RESEARCH CONSORTIUM, ESTABLISHED IN 1999, PRIMARILY FOCUSES ON DEVELOPING NEW TOLEROGENIC APPROACHES FOR TREATING AND PREVENTING DISEASES IN THREE CLINICA…
INTERVENTIONAL IMMUNOLOGYSTUDYING HEALTH TO UNDERSTAND DISEASEIN JUNE 2025, A TEAM OF BRI SCIENTISTS LEAD BY JANE BUCKNER, MD, CATE SPEAKE, PHD, MEGAN SMITHMYER, PHD, AND ALEX HU, PHD, PUBLISHED FINDINGS FROM THE SOUND LIFE PROJECT, A UNIQUE LONGITUDINAL STUDY INVESTIGATING HOW HEALTHY IMMUNE SYSTEMS DIFFER FROM EACH OTHER. THE STUDY FOLLOWED 100 HEALTHY INDIVIDUALS FOR TWO YEARS, AND PARTICIPANTS DONATED BLOOD SAMPLES OVER 10 VISITS AND SELF-REPORTED INFORMATION ABOUT DIET, EXERCISE, TRAVEL AND HEALTH THROUGH WEEKLY SURVEYS.IN THIS FIRST PUBLICATION, THE INVESTIGATORS MEASURED 174 DIFFERENT …
FUNDAMENTAL IMMUNOLOGY OR BASIC DISCOVERYUNDERSTANDING HOW TARGETING SPECIFIC REGULATORY CELLS COULD LEAD TO NEW WAYS TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)IN NOVEMBER 2024, STEVE ZIEGLER, PHD, A PRINCIPAL INVESTIGATOR IN BRI'S CENTER FOR FUNDAMENTAL IMMUNOLOGY, RECEIVED A GRANT FROM THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES OF THE NATIONAL INSTITUTES OF HEALTH TO INVESTIGATE HOW A SUBSET OF REGULATORY CELLS IS DYSFUNCTIONAL IN CONTROLLING AUTOANTIBODY PRODUCTION IN INDIVIDUALS WITH SLE.THIS WORK BUILDS OFF DECADES OF DR. ZIEGLER'S PREVIOUS RESEARCH INTO FOXP3, A CRITICAL…
Public charity (Medical research) · 82.8% public support
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202621339349307917). Not an official IRS form.